Discordant effects of rosiglitazone on novel inflammatory biomarkers - Gada, Elan; Owens, Andrew W.; Gore, M. Odette; See, Raphael; Abdullah, Shuaib M.; Ayers, Colby R.; Rohatgi, Anand; Khera, Amit; de Lemos, James A.; McGuire, Darren K. (The American heart journal, 2013)
Keywords: Aged; Atherosclerosis; Atherosclerosis - blood; Atherosclerosis - physiopathology; Biomarkers; Biomarkers - blood; C-Reactive Protein - analysis; C-Reactive Protein - drug effects; Cardiovascular; Cardiovascular disease; Chemokines; Cholesterol; Cytokines - drug effects; Diabetes; Diabetes Mellitus, Type 2 - blood; Female; Glycation End Products, Advanced - drug effects; Heart attacks; Humans; Hypertension; Hypoglycemic Agents - adverse effects; Hypoglycemic Agents - pharmacology; Ligands; Lymphotoxin beta Receptor - drug effects; Male; Middle Aged; Myocardial Infarction - chemically induced; Pilot Projects; Proteins; Studies; Thiazolidinediones - adverse effects; Thiazolidinediones - pharmacology